Spots Global Cancer Trial Database for uterine cervical cancer
Every month we try and update this database with for uterine cervical cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Paracetamol With or Without Ketoprofen in the Management of Pain for Patients Receiving Brachytherapy (KETOCOL-1304) | NCT02439034 | Uterine Cervica... Upper Aerodiges... | Paracetamol Ketoprofen | 18 Years - 75 Years | Centre Oscar Lambret | |
Weekly Paclitaxel/Carboplatin With Neupogen in Gynaecological Cancers | NCT01523678 | Ovarian Cancer Endometrial Can... Uterine Cervica... | Filgrastim Paclitaxel Carboplatin | 18 Years - | Belgian Gynaecological Oncology Group | |
Study of Zoledronic Acid Versus Observation on Bone Mineral Density and Incidence of Micrometastasis in Women Undergoing Pelvic Radiation for Cervical Cancer | NCT00966992 | Uterine Cervica... | Zoledronic acid | 18 Years - | Washington University School of Medicine | |
DNA Methylation for Screening Uterine Cervical Lesions | NCT03960879 | DNA Methylation Uterine Cervica... High Grade Squa... Low Grade Squam... | DNA methylation High-risk HPV TCT | 18 Years - | Peking Union Medical College Hospital | |
Evaluation of First-void Urine as an Alternative to Cervical Sampling for Human Papillomavirus (HPV) Testing in Cervical Cancer Screening (Single-center Study). | NCT06254846 | Uterine Cervica... | Urine sample, 1... Cervico-vaginal... | 30 Years - 65 Years | Centre Hospitalier Universitaire de Saint Etienne | |
Study of the SG001 Injection for Patients With Relapsed or Metastatic Uterine Cervical Cancer | NCT04886700 | Uterine Cervica... | SG001 | 18 Years - | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | |
To Determine Safe and Effective Dose of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Participants With Advanced Non-small Cell Lung Cancer | NCT01284348 | Anemia Carcinoma, Non-... Carcinoma, Smal... Bladder Cancer Cancer of Head ... Uterine Cervica... | Sotatercept 15 ... Sotatercept 30 ... | 18 Years - | Merck Sharp & Dohme LLC | |
A Study of the Safety, Tolerability, and Immunogenicity of a 9-valent Human Papillomavirus Vaccine ([9vHPV]; V503) Administered to 9- to 15-Year-Old Japanese Girls (V503-008). | NCT01254643 | Papillomavirus ... | V503 | 9 Years - 15 Years | Merck Sharp & Dohme LLC | |
Evaluation of Long-term HPV Vaccine Efficacy | NCT01393470 | Uterine Cervica... | Screening for c... | 16 Years - 19 Years | Tampere University | |
Adaptative Radiotherapy for Locally Advanced Cervical Cancer | NCT02937948 | Uterine Cervica... | Adaptative trea... External radiot... | 18 Years - | Center Eugene Marquis | |
Three Birds With One Stone | NCT05022511 | Uterine Cervica... Uterine Cervix ... Uterine Cervica... Colorectal Neop... Colorectal Canc... Colorectal Carc... Mass Screening Early Detection... | Screening statu... | 50 Years - 69 Years | University of Aarhus | |
Study of Gemcitabine and Concurrent Radiation Followed by Adjuvant Hysterectomy in Bulky Stage Ib and IIa Cervical Carcinoma | NCT00184093 | Uterine Cervica... | Gemcitabine | 18 Years - | University of Southern California | |
Early Warning Model of Susceptibility and High-risk Population of Cervical Cancer Related to HPV | NCT04974424 | Uterine Cervica... Uterine Cervica... Cervical Cancer | 25 Years - 75 Years | Huazhong University of Science and Technology | ||
Radiochemotherapy Followed by Adjuvant Chemotherapy Based on Gemcitabine in Uterine Cervical Cancer | NCT00421096 | Uterine Cervica... | Gemcitabine Radiotherapy Cisplatin | 18 Years - 70 Years | Centre Oscar Lambret | |
Adaptative Radiotherapy for Locally Advanced Cervical Cancer | NCT02937948 | Uterine Cervica... | Adaptative trea... External radiot... | 18 Years - | Center Eugene Marquis | |
Clinical Trial for the Use of a Novel Cell Collector Device to Retrieve Cells From the Uterine Cervix | NCT00266084 | Uterine Cervica... Uterine Cervica... Uterine Cervica... Uterine Cervica... | 14 Years - | University Hospitals Cleveland Medical Center | ||
Evaluation of First-void Urine as an Alternative to Cervical Sampling for Human Papillomavirus (HPV) Testing in Cervical Cancer Screening (Single-center Study). | NCT06254846 | Uterine Cervica... | Urine sample, 1... Cervico-vaginal... | 30 Years - 65 Years | Centre Hospitalier Universitaire de Saint Etienne | |
Clinical Triage and Treatment of Atypical Glandular Cells (AGC) Detected in Screening | NCT05231993 | Uterine Cervica... | Conization Colposcopy | 23 Years - 64 Years | Karolinska Institutet | |
DNA Methylation for Screening Uterine Cervical Lesions | NCT03960879 | DNA Methylation Uterine Cervica... High Grade Squa... Low Grade Squam... | DNA methylation High-risk HPV TCT | 18 Years - | Peking Union Medical College Hospital | |
To Determine Safe and Effective Dose of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Participants With Advanced Non-small Cell Lung Cancer | NCT01284348 | Anemia Carcinoma, Non-... Carcinoma, Smal... Bladder Cancer Cancer of Head ... Uterine Cervica... | Sotatercept 15 ... Sotatercept 30 ... | 18 Years - | Merck Sharp & Dohme LLC | |
Radiochemotherapy Followed by Adjuvant Chemotherapy Based on Gemcitabine in Uterine Cervical Cancer | NCT00421096 | Uterine Cervica... | Gemcitabine Radiotherapy Cisplatin | 18 Years - 70 Years | Centre Oscar Lambret | |
Evaluation of Long-term HPV Vaccine Efficacy | NCT01393470 | Uterine Cervica... | Screening for c... | 16 Years - 19 Years | Tampere University | |
Study of Zoledronic Acid Versus Observation on Bone Mineral Density and Incidence of Micrometastasis in Women Undergoing Pelvic Radiation for Cervical Cancer | NCT00966992 | Uterine Cervica... | Zoledronic acid | 18 Years - | Washington University School of Medicine | |
Early Warning Model of Susceptibility and High-risk Population of Cervical Cancer Related to HPV | NCT04974424 | Uterine Cervica... Uterine Cervica... Cervical Cancer | 25 Years - 75 Years | Huazhong University of Science and Technology | ||
ENGOT-cx1/BGOG-cx1: 3 Weekly Carboplatin/Paclitaxel With or Without Nintedanib in Cervix Cancer | NCT02009579 | Uterine Cervica... | Nintedanib Placebo | 18 Years - | Belgian Gynaecological Oncology Group | |
Clinical Triage and Treatment of Atypical Glandular Cells (AGC) Detected in Screening | NCT05231993 | Uterine Cervica... | Conization Colposcopy | 23 Years - 64 Years | Karolinska Institutet | |
A Cohort Study for the Following up of Conization | NCT03961178 | Precancerous Le... Conization High Grade Intr... Uterine Cervica... Fertility Pregnancy Human Papilloma... | High-risk HPV TCT | 18 Years - | Peking Union Medical College Hospital | |
Clinical Study of Albumin-bound Paclitaxel Plus Nedaplatin in Cervical Cancer | NCT01667211 | Uterine Cervica... | albumin-bound p... | 18 Years - 70 Years | ChineseAMS | |
A Multicenter, Prospective, Randomized Trial of Adjuvant Chemotherapy for Early-Stage Cervical Cancer Patients | NCT01755897 | Uterine Cervica... Cervical Cancer Uterine Cervica... | radical hystere... Paclitaxel Cisplatin Cisplatin Pelvic RT | - 65 Years | Huazhong University of Science and Technology | |
A Study of the Safety, Tolerability, and Immunogenicity of a 9-valent Human Papillomavirus Vaccine ([9vHPV]; V503) Administered to 9- to 15-Year-Old Japanese Girls (V503-008). | NCT01254643 | Papillomavirus ... | V503 | 9 Years - 15 Years | Merck Sharp & Dohme LLC | |
Clinical Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic Chemotherapy | NCT00900562 | Uterine Cervica... Endometrial Can... | Zalypsis ( PM00... | 18 Years - | PharmaMar | |
Specific Molecular Signatures Predict Neoadjuvant Chemotherapy Response in Cervical Cancer | NCT03229187 | Uterine Cervica... Cervical Cancer Uterine Cervica... | 18 Years - 70 Years | Huazhong University of Science and Technology | ||
The Prospective Cohort Study to Evaluate the Preventive Efficacy of HPV Vaccine in Japanese Women Aged 27-45 Years | NCT04022148 | Cancer of Cervi... Vaccinia | Gardasil | 27 Years - 45 Years | University of Fukui | |
Specific Molecular Signatures Predict Neoadjuvant Chemotherapy Response in Cervical Cancer | NCT03229187 | Uterine Cervica... Cervical Cancer Uterine Cervica... | 18 Years - 70 Years | Huazhong University of Science and Technology | ||
Study of Gemcitabine and Concurrent Radiation Followed by Adjuvant Hysterectomy in Bulky Stage Ib and IIa Cervical Carcinoma | NCT00184093 | Uterine Cervica... | Gemcitabine | 18 Years - | University of Southern California | |
Cadonilimab Plus Nab -Paclitaxel for Patients With Recurrent, or Metastatic Cervical Cancer Resistant to Immune Checkpoint Inhibitors | NCT05824494 | Uterine Cervica... Cancer of Cervi... Cervical Cancer Cervical Neopla... Uterine Cervica... Cancer of the U... | Cadonilimab Nab paclitaxel | 18 Years - 75 Years | Women's Hospital School Of Medicine Zhejiang University |